Sino BiologicalSino Biological Deposits Recombinant Omicr...Sino Biological, Inc. has recently deposited reagents for the Omicron variant, including recombinant proteins to Spike and Nucleocapsid, and antibody products to a central repository for reagents to … more ➔
Accelerating biologics developmentAbstract: This report provides a roadmap for assessing and selecting the right partner to get promising biological therapies to patients quickly. Criteria includes: more ➔
Accelerating biologics developmentAbstract: This report provides a roadmap for assessing and selecting the right partner to get promising biological therapies to patients quickly. Criteria includes: more ➔
Sino BiologicalSino Biological Newly Launched A Panel of...Sino Biological, Inc. announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus, which quickly raised concerns around … more ➔
A SARS-CoV-2-specific T cell isolation met...The COVID-19 pandemic created exceptional circumstances for virologists. To speed up the process from initial basic experiments to the final clinical application, appropriate reagents are required. Isolation … more ➔
Managing risks and finding opportunities...By applying the expertise, best practice, and emerging technologies of the logistics industry, biotech not only prevents the missteps that can destroy its products, it can also capitalise on opportunities … more ➔
Pioneers of Omics Virtual Event Series New, ongoing, free event series about researchers work in the exciting fields of multi-omics. Each session will take a particular field of omics research and showcase some of the exciting research being … more ➔
A modern electron microscope (cryo-EM) ava...Easier access for central European companies to cryo-EM technique! A modern Thermo Scientific Glacios transmission electron microscope has just been installed at Synchrotron Solaris in Poland and … more ➔
Benefits of 5000 L single-use bioreactorsThis white paper focuses on a new generation of single-use bioreactors, built to deliver high-volume performance and how they address many issue. more ➔
IZB start-up: Eisbach Bio GmbHEisbach Bio GmbH is a spin-off of the Ludwig Maximilian University in Munich. The company is located in the Innovation and Start-up Centre IZB in Planegg-Martinsried. more ➔
